Article
Simplified and Rapid Workflow Enhances Throughput of <i>De Novo</i> Sequencing of COVID-19 Neutralizing Antibodies
2024-08-12
Abstract excerpt
<h4>ABSTRACT</h4> During the current COVID-19 pandemic, precise antibody sequencing is crucial for the rapid development of broad-spectrum or pan-β-coronavirus neutralizing antibodies (NAbs) to prevent new variants of the coronavirus and other highly pathogenic β-coronaviruses. However, mass spectrometry-based de novo sequencing remains challenging due to its high cost, low throughput, and unexpected missing of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 042db850-6ead-5077-bc54-f8106ae9d495
- DOI
- 10.1101/2024.08.09.607349
